Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Kabra Drugs LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524322NSE Symbol: Not ListedP/E(TTM):14.57
ISIN Demat:INE323K01017Div & Yield %:0EPS(TTM):1.81
Book Value(Rs):10.9633096Market Cap ( Cr.):62.52Face Value(Rs):10
    Change Company 
Date Headline
27-Feb-26 Kabra Drugs schedules board meeting
14-Feb-26 Kabra Drugs reports standalone net profit of Rs2.57 crore in the December 2025 quarter
06-Feb-26 Kabra Drugs to discuss results
22-Dec-25 Kabra Drugs to convene board meeting
21-Nov-25 Kabra Drugs to conduct board meeting
14-Nov-25 Kabra Drugs reports standalone net profit of Rs1.84 crore in the September 2025 quarter
06-Nov-25 Kabra Drugs to table results
08-Oct-25 Kabra Drugs Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On 08 Th October 2025 As Per Regulation 30 Of ..
08-Oct-25 Kabra Drugs Ltd - Announcement under Regulation 30 (LODR)-Change in Management
08-Oct-25 Kabra Drugs Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director
<< < 1 2 3 > >>